Hikma Injectables USA Inc 2024-05-29 Health critical FDA
Health · FDA · Recall #FDA-D-0508-2024
Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL… Recall
Issued May 29, 2024 · Hikma Injectables USA Inc
In May 2024, Hikma Injectables USA Inc recalled the Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
What you should do
- 1 Stop using Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Hikma Injectables USA Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Hikma Injectables USA Inc
- Category
- Health
- Recall date
- May 29, 2024
- Units affected
- Not reported
- Sold at
- CO, GA, PA, SD, WA
- Recall number
- FDA-D-0508-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Hikma Injectables USA Inc has 2 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.